View
234
Download
4
Category
Preview:
Citation preview
3
Drug profile 皮膚科
96/12/01 96/12/04 96/12/11 96/12/20
Prednisolone 5mg/tab 2# TID 2# TID 1# QID
Cetirizine 10mg/tab 1# HS
Amitriptyline 25mg/tab 1# HS
Gabapentin 100mg/cap 1# BID
Homochlorcyclizine 10mg/tab 1# TID
Hydroxyzine 25mg/cap 1# TID
Doxepin cream 5% 15g/tube 1QS TID
Fluocinonide cream 0.05% 5g/tube 1QS QID
Hydrocortisone 10mg +Urea 100mg/g 10g/tube
1QS BID
Mometasone cream 0.1% 5g/tube 1QS QD
4
Drug profile 免疫風濕科
98/03/31
98/04/07
98/04/14
98/04/28
98/05/12
98/05/26
98/06/12
Loratadine 10mg/tab 1# QD
Dexchlorpheniramine 2mg/tab 1# QD ~ TID
Cetirizine 10mg/tab 1# QD
Colchicine 0.5mg/tab 1# QD
Fexofenadine 180mg/tab 1# QD
Cyproheptadine 4mg/tab
1# HS
C.B. ointment 5g/tube 1QS BID
Fluocinonide cream 0.05% 5g/tube 1QS BID
Hydrocortisone 10mg +Urea 100mg/g 10g/tube
1QS BID
Mometasone cream 0.1% 5g/tube 1QS BID
因病患蕁麻疹之症狀改善 DC colchicine 但是,由於病患腳部仍有先前尚未痊癒的皮膚症狀因此持續給予口服 antihistamine
5
OUTLINE
Classification Urticarial vasculitis Colchicine in the treatment of Urticarial vasculit
is Conclusion
6
Cutaneous vasculitis. Classification
HSP: Henoch-Sch¨onlein purpura, CLA: cutaneous leukocytoclastic angiitis, PAN: polyarteritis nodosa, Nod Vas: nodular vasculitis, GCA: giant cell arteritis, CV: cryoglobulinemic vasculitis, CTD: connective tissue disease, ANCA+: antineutrophil cytoplasmic antibody positive vasculitis,
Classification of cutaneous vasculitis can be initially based on Histopathology (vessel size, inflammatory infiltrate and immunoreactants.), clinical and laboratory features and etiology.
Am J Clin Dermatol 2008; 9 (2): 71-92
7
Urticarial vasculitis Introduction
The initial report by McDuffie et al. in 1973 Urticarial vasculitis is a clinico-pathologic entity typified by re
current episodes of urticaria Histopathologic features of leukocytoclastic vasculitis Classified as primary, secondary
Epidemiology A relatively rare condition Most commonly seen in individuals between 30 and 50 years
of age with a 3:1 female to male predominance. Feature Laboratory findings
Clinical Reviews in Allergy and Immunology. 2002;23:201-216
Southern Medical Journal. 2009;102:531-533
14
Urticarial vasculitis treated with colchicine
Micromedex Non-FDA Labeled Indications : Vasculitis
General 0.5 to 0.6 milligram 2 to 3 times daily treatment of refractory urticarial vasculitis, leukocytoclastic v
asculitis, and mononuclear vasculitis 1 study (Callen, 1985) reported the successful use of colchic
ine in 12 out of 13 patients with chronic cutaneous leukocytoclastic vasculitis.
0.6 milligram orally twice daily Improvement was observed within 7 to 10 days following the i
nitiation of therapy. 1 study colchicine was no more effective than topical emoll
ients in the treatment of cutaneous leukocytoclastic vasculitis (Sais et al, 1995).
Micromedex
16
Conclusion
Urticarial vasculitis is a subtype of leuko-cytoclastic vasculitis.
Colchicine have inhibit neutrophil chemotaxis, but with no controlled studies with small samples and completely proven efficacy.
At present is unknown that urticarial vasculitis treated with colchicine.
Arch dermatol 1995;131:1399-1402
Clinical Reviews in Allergy and Immunology. 2002;23:201-216
17
Reference Joe Venzor, Wai L. Lee, David P. Huston. Urticarial Vasculitis. Clinical Reviews in Allergy
and Immunology. 2002;23:201-216 . Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria
and angio-edema. Br J Dermatol. 2001;144:708-14. Ko-Ron Chen, J. Andrew Carlson. Clinical Approach to Cutaneous Vasculitis. Am J Clin D
ermatol 2008;9(2):71-92. Criado PR, Criado RFJ, Maruta CW, et. al. Urticaria. An Bras Dermatol. 2005;80(6):613-32. Landon E. Stigall, Justin R. Sigmon, and Stuart S. Leicht. Urticarial Vasculitis: A Unique
Presentation. Southern Medical Journal. 2009;102(5):531-533. 林靖麒 , 楊麗珍 , 林宜婷 et al. 皮膚血管炎 -- 不同致病因之臨床分析 . J Rheumatol R.O.C.
2007;21:32-43. Micromedex
Recommended